« Previous
Next »
Titles
- Labeling for biosimilar products1
- Laser products: conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 : (Laser Notice No. 56) : guidance for industry and Food and Drug Administration staff1
- Latex: a lingering and lurking safety risk1
- Latino immigrants have higher rates of health insurance in states with inclusive policies1
- Leaning in to succeed in public hospitals1
- Left behind in California: comparing community paramedicine policies across states1
- Legacy Community Health Services v. Smith: what are the national implications for community health centers and their communities?1
- Legionella: could this potentially deadly bacteria be lurking in your facility's water distribution system?1
- Legislative priorities for the 116th Congress1
- Lessons learned from payer-provider partnerships for community-based palliative care1
- Leveraging 1332 state innovation waivers to stabilize individual health insurance markets: experiences of Alaska, Minnesota, and Oregon : final report : document efforts to stabilize the individual market using state-based reinsurance1
- Liposome drug products: chemistry, manufacturing, and controls : human pharmacokinetics and bioavailability : and labeling documentation1
- Listening to Mothers in California: results from a population-based survey of women's childbearing experiences1
- Listening to Trump voters with ACA coverage: what they want in a health care plan1
- Listing of ingredients in tobacco products: (revised)1
- Litigation challenging Title X regulations1
- Live case presentations during investigational device exemption (IDE) clinical trials: guidance for institutional review boards, industry, clinical investigators, and Food and Drug administration staff1
- Living in an immigrant family in America: how fear and toxic stress are affecting daily life, well-being, & health1
- Local lunches: a "win-win" for New York State's farmers and students1
- Logical observation identifiers names and codes for in vitro diagnostic tests: guidance for industry and Food and Drug Administration staff1